These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21802411)

  • 1. Human holocarboxylase synthetase with a start site at methionine-58 is the predominant nuclear variant of this protein and has catalytic activity.
    Bao B; Wijeratne SS; Rodriguez-Melendez R; Zempleni J
    Biochem Biophys Res Commun; 2011 Aug; 412(1):115-20. PubMed ID: 21802411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three promoters regulate the transcriptional activity of the human holocarboxylase synthetase gene.
    Xia M; Malkaram SA; Zempleni J
    J Nutr Biochem; 2013 Nov; 24(11):1963-9. PubMed ID: 24075901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holocarboxylase synthetase interacts physically with nuclear receptor co-repressor, histone deacetylase 1 and a novel splicing variant of histone deacetylase 1 to repress repeats.
    Liu D; Zempleni J
    Biochem J; 2014 Aug; 461(3):477-86. PubMed ID: 24840043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of holocarboxylase synthetase in genome stability is mediated partly by epigenomic synergies between methylation and biotinylation events.
    Zempleni J; Li Y; Xue J; Cordonier EL
    Epigenetics; 2011 Jul; 6(7):892-4. PubMed ID: 21555910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel roles of holocarboxylase synthetase in gene regulation and intermediary metabolism.
    Zempleni J; Liu D; Camara DT; Cordonier EL
    Nutr Rev; 2014 Jun; 72(6):369-76. PubMed ID: 24684412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holocarboxylase synthetase knockout is embryonic lethal in mice.
    Sadri M; Wang H; Kuroishi T; Li Y; Zempleni J
    PLoS One; 2022; 17(4):e0265539. PubMed ID: 35385533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential growth inhibition, cell cycle arrest and apoptosis of MCF-7 and MDA-MB-231 cells to holocarboxylase synthetase suppression.
    Siritutsoontorn S; Sukjoi W; Polyak SW; Akekawatchai C; Jitrapakdee S
    Biochem Biophys Res Commun; 2022 Feb; 593():108-115. PubMed ID: 35063765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats.
    Xue J; Wijeratne SS; Zempleni J
    Epigenetics; 2013 May; 8(5):504-11. PubMed ID: 23624957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency.
    Morrone A; Malvagia S; Donati MA; Funghini S; Ciani F; Pela I; Boneh A; Peters H; Pasquini E; Zammarchi E
    Am J Med Genet; 2002 Jul; 111(1):10-8. PubMed ID: 12124727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency.
    Yang X; Aoki Y; Li X; Sakamoto O; Hiratsuka M; Kure S; Taheri S; Christensen E; Inui K; Kubota M; Ohira M; Ohki M; Kudoh J; Kawasaki K; Shibuya K; Shintani A; Asakawa S; Minoshima S; Shimizu N; Narisawa K; Matsubara Y; Suzuki Y
    Hum Genet; 2001 Nov; 109(5):526-34. PubMed ID: 11735028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Holocarboxylase Synthetase Predicts Lymph Node Metastasis and Unfavorable Prognosis in Breast Cancer.
    Sukjoi W; Siritutsoontorn S; Chansongkrow P; Waiwitlikhit S; Polyak SW; Warnnissorn M; Charoensawan V; Thuwajit C; Jitrapakdee S
    Anticancer Res; 2020 Aug; 40(8):4557-4565. PubMed ID: 32727786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Keto and β-hydroxyphosphonate analogs of biotin-5'-AMP are inhibitors of holocarboxylase synthetase.
    Sittiwong W; Cordonier EL; Zempleni J; Dussault PH
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5568-5571. PubMed ID: 25466176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single-nucleotide polymorphisms in the human holocarboxylase synthetase gene on enzyme catalysis.
    Esaki S; Malkaram SA; Zempleni J
    Eur J Hum Genet; 2012 Apr; 20(4):428-33. PubMed ID: 22027809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol compounds inhibit human holocarboxylase synthetase and cause a lean phenotype in Drosophila melanogaster.
    Cordonier EL; Adjam R; Teixeira DC; Onur S; Zbasnik R; Read PE; Döring F; Schlegel VL; Zempleni J
    J Nutr Biochem; 2015 Nov; 26(11):1379-84. PubMed ID: 26303405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the holocarboxylase synthetase gene HLCS.
    Suzuki Y; Yang X; Aoki Y; Kure S; Matsubara Y
    Hum Mutat; 2005 Oct; 26(4):285-90. PubMed ID: 16134170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holocarboxylase synthetase catalyzes biotinylation of heat shock protein 72, thereby inducing RANTES expression in HEK-293 cells.
    Xue J; Zhou J; Zempleni J
    Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1240-5. PubMed ID: 24133061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical, and genetic analysis of a Chinese Han pedigree with holocarboxylase synthetase deficiency: a case report.
    Zheng Z; Yuan G; Zheng M; Lin Y; Zheng F; Jiang M; Zhu L; Fu Q
    BMC Med Genet; 2020 Jul; 21(1):155. PubMed ID: 32727382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiency.
    Tang NL; Hui J; Yong CK; Wong LT; Applegarth DA; Vallance HD; Law LK; Fung SL; Mak TW; Sung YM; Cheung KL; Fok TF
    Clin Biochem; 2003 Mar; 36(2):145-9. PubMed ID: 12633764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity in post-translational biotin addition to five human carboxylases.
    Ingaramo M; Beckett D
    J Biol Chem; 2012 Jan; 287(3):1813-22. PubMed ID: 22123817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine methylation in miR-153 gene promoters increases the expression of holocarboxylase synthetase, thereby increasing the abundance of histone H4 biotinylation marks in HEK-293 human kidney cells.
    Bao B; Rodriguez-Melendez R; Zempleni J
    J Nutr Biochem; 2012 Jun; 23(6):635-9. PubMed ID: 21764280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.